Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading. - Wikidata - wikimedia - TriplyDB

Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading.

Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading.

http://www.wikidata.org/entity/Q36857952

about

Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis Quantification of fibrosis and osteosclerosis in myeloproliferative neoplasms: a computer-assisted image study.Myelofibrotic transformations of polycythemia vera and essential thrombocythemia are morphologically, biologically, and prognostically indistinguishable from primary myelofibrosis.WHO classification of myeloproliferative neoplasms (MPN): A critical update.Dilemmas in a pregnant woman with myelofibrosis secondary to signet ring adenocarcinoma: a case report.Differential diagnosis of myelofibrosis based on WHO 2008 criteria: acute panmyelosis with myelofibrosis, acute megakaryoblastic leukemia with myelofibrosis, primary myelofibrosis and myelodysplastic syndrome with myelofibrosis.Prostaglandin transporter mutations cause pachydermoperiostosis with myelofibrosis.Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis.Problems and pitfalls in grading of bone marrow fibrosis, collagen deposition and osteosclerosis - a consensus-based study.Marked regression of myelofibrosis during reduced-dose dasatinib treatment in chronic myelogenous leukemia in accelerated phase.High concordance in grading reticulin fibrosis and cellularity in patients with myeloproliferative neoplasms.

P2860

Q24186554-4346DEF8-9DEE-40E8-B563-2B102E1FDA80 Q24201893-EABFE183-513B-4B6E-B2A8-F58B79204307 Q33872534-867341B0-A54E-4503-AF24-F926F32628CC Q35386991-F874705C-8444-4810-A950-CD758343BEA9 Q38154519-531FB673-12BE-4F9B-8A25-79DD3FB4D372 Q42375176-3D5E87F2-BC9F-4F90-A286-F24D27DEBC6F Q44292097-5B8F7287-4348-4104-A5FD-5CD5B84A3189 Q45345301-6267BA7B-78CA-4DB4-9A59-716B44F6D0C3 Q51733623-BD6B236C-34CF-4CDB-8B95-45979DBA6EE6 Q52862082-D6788ACC-0B85-4A79-AA6E-53E3FD90852C Q53454643-17479111-E395-4C0A-8400-667783C34AA7 Q54357496-76240F41-5102-4830-BA95-D1BB39F4CA83

P2860

Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading.

http://www.wikidata.org/entity/Q36857952

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading.

@en

type

label

Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading.

@en

prefLabel

Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading.

@en

P1433

Q36857952-04AF1F77-8E77-4EB5-BA64-4F40C76649A6

P1476

Q36857952-DCD06072-115E-411F-B799-68CE1533AF00

P2093

Q36857952-3B49F669-E878-4C83-B31F-E0C275EE7969

Q36857952-D9EF43C3-8C11-4832-BAE5-4C67F87345CB

P2860

Q36857952-052CF429-F997-4828-9D14-5CBB592420BF

Q36857952-0E8D69D0-D744-4CFE-9257-E1F6D404E7A0

Q36857952-17FD6D86-288E-473E-B741-48180A08CD9E

Q36857952-18E83361-597E-4BC1-869D-91500D6D0A0E

Q36857952-1A2ABC4F-14FE-4831-9989-2227D3E6ABA5

Q36857952-2C328B87-D3E4-4AAB-854F-3F732A7DFCF2

Q36857952-327EF3D6-6FCD-4517-97D2-33D7E0A7C865

Q36857952-33043903-7CC2-4E26-9CFC-B68C3626F99A

Q36857952-35BA3035-EFEE-4BAC-A3B1-265AD08D8DD0

Q36857952-3FC12072-B296-45E9-8BC5-8CE74E099572

P304

Q36857952-03E723DD-4EC0-4F91-9C97-2DB404587882

P31

Q36857952-BFB38CEF-421B-4B99-8553-49684B96FD0E

P356

Q36857952-E7D0CF29-41EB-43FC-8FEE-D0D1A45D1932

P433

Q36857952-8AF9CB9C-3C85-49D7-BF06-BB3D7A5505A1

P478

Q36857952-11166C0A-F590-48C1-8A68-DF03C0E91DF4

P577

Q36857952-66FEEECD-B5AF-49A4-9EC6-3FC2771FE1AF

P698

Q36857952-5686ADE1-CE47-4248-9FC5-BB0EA813C87E

P356

P1433

P1476

Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading.

@en

P2093

Hans M Kvasnicka

http://www.w3.org/2001/XMLSchema#string

Jürgen Thiele

http://www.w3.org/2001/XMLSchema#string

P2860

Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia

When and how to treat essential thrombocythemia

Agnogenic myeloid metaplasia (AMM)--correlation of bone marrow lesions with laboratory data: a longitudinal clinicopathological study on 114 patients.

Clinicopathological diagnosis and differential criteria of thrombocythemias in various myeloproliferative disorders by histopathology, histochemistry and immunostaining from bone marrow biopsies.

Transformation of chronic myelogenous leukemia: clinical, morphologic, and cytogenetic features.

The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid Metaplasia.

Chronic myelogenous leukemia: biology and therapy.

Histochemistry and morphometry on bone marrow biopsies in chronic myeloproliferative disorders - aids to diagnosis and classification.

Diagnosis and classification of erythrocytoses and thrombocytoses.

The histopathology of chronic myeloproliferative diseases.

P304

89-96

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000101708

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17587880

http://www.w3.org/2001/XMLSchema#string